Related Experiment Video
Updated: Nov 3, 2025

Microsampling in Targeted Mass Spectrometry-Based Protein Analysis of Low-Abundance Proteins
Published on: January 13, 2023
GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting
Denis P O'Sullivan1, Ingrid Steinkoenig2
1D.P. O'Sullivan, BE, Our Lady's Hospice & Care Services, Rheumatic & Musculoskeletal Disease Unit, Dublin, Ireland; denis_osullivan@ymail.com.
Abstract:
Eleven patient research partners (PRPs) attended the virtual Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2020 Annual Meeting. PRPs fully participated in the panel discussion at the 2020 GRAPPA Annual Meeting on the topic of the coronavirus disease 2019 (COVID-19; caused by SARS-CoV-2). The members of the PRP group have been involved in many GRAPPA projects over the last year, including work on the GRAPPA-Outcome Measures in Rheumatology (OMERACT) Core Set, GRAPPA's 2020 Treatment Guidelines update project, and GRAPPA's Collaborative Research Network project.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Chronic Pancreatitis II: Collaborative Care
Assessment:
Patient-centered Care
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

